As a technology reporter and facial enthusiast, I visited a GLO30 studio in Columbia, Md.—one of its 12 U.S.

Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.

Researchers used tissue samples from patients with an inflammatory skin disease called hidradenitis suppurativa to gain insights into inflammation patterns before and after drug exposure.

Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for ...